SpringWorks Therapeutics Inc (NASDAQ:SWTX) has entered into an expanded global, non-exclusive license and collaboration agreement with GSK plc (NYSE:GSK) for SpringWorks’ nirogacestat with…
Akouos (NASDAQ:AKUS) reported quarterly losses of $(0.58) per share. This is a 12.12 percent increase over losses of $(0.66) per share from the same period last year.